Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Published on by Forensic Scientist

Prof. Liliang Li | Medicine and Health Sciences | Excellence in Innovation Award

Fudan University | China

Prof. Liliang Li is a leading Associate Professor at Fudan University Shanghai Medical College, recognized for her pioneering research in forensic medicine, cardiovascular biology, and translational pharmacology. She has made significant contributions to understanding the molecular mechanisms underlying antipsychotic-induced cardiotoxicity, diabetic heart injuries, and sudden unexplained death in psychiatric patients. Combining innovative molecular approaches with clinical applications, Dr. Li’s research has consistently bridged basic science and translational medicine, influencing both diagnostic strategies and therapeutic development.

Professional Profile

Scopus

ORCID

Education

Prof. Liliang Li received her medical degree in Forensic Medicine followed by a doctoral degree in Forensic Science from Fudan University Shanghai Medical College. She enhanced her academic foundation and international exposure through postdoctoral training and a visiting scholar program at the University of Maryland School of Medicine, enabling her to integrate global perspectives into her research.

Experience

Prof. Liliang Li has built an impressive academic and research career, progressing from postdoctoral fellow to Associate Research Fellow, and ultimately assuming her current role as Associate Professor. She has played key roles in mentoring young researchers, organizing graduate research conferences, and serving as a talent specialist. She actively participates in professional committees, including leadership positions within the Shanghai Society of Forensic Medicine, the Shanghai Association of Forensic Expertise, and cardiovascular research societies, demonstrating both scientific excellence and professional commitment.

Research Interests

Her research focuses on the mechanisms of antipsychotic-induced cardiotoxicity, cannabinoid receptor-mediated myocardial signaling, and cell death pathways including necroptosis and pyroptosis. Prof. Liliang Li is particularly interested in the identification of biomarkers for sudden cardiac death and diabetic cardiac injuries. Her work integrates multi-omics approaches, including proteomics, transcriptomics, and molecular biology, to unravel complex cardiovascular and forensic phenomena, with an emphasis on developing translational strategies for clinical and forensic applications.

Awards

Prof. Liliang Li’s innovative work has been widely recognized with numerous prestigious awards, including Young Investigator accolades, national and regional medical science awards, and multiple best paper honors at leading cardiology conferences. She has been nominated for international awards in toxicology, chaired sessions at major scientific meetings, and serves as a reviewer for high-impact journals in cardiovascular medicine, translational research, and molecular biology. These accolades reflect her influence on both national and international scientific communities.

Publications

  • Title: Coenzyme Q deficiency may predispose to sudden unexplained death via an increased risk of cardiac arrhythmia
    Journal: International Journal of Legal Medicine
    Published on: 2024

  • Title: RNF149 Destabilizes IFNGR1 in Macrophages to Favor Postinfarction Cardiac Repair
    Journal: Circulation Research
    Published on: 2024

  • Title: Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
    Journal: Clinical Science
    Published on: 2024

  • Title: Post-mortem genetic analysis of sudden unexplained death in a young cohort: a whole-exome sequencing study
    Journal: International Journal of Legal Medicine
    Published on: 2023

  • Title: Nasal mucosa is much more susceptible than oral mucosa to infection of SARS‐CoV‐2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used
    Journal: Journal of Medical Virology
    Published on: 2023

  • Title: Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China
    Journal: Asian Journal of Psychiatry
    Published on: 2023

  • Title: Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries
    Journal: Circulation
    Published on: 2023

Conclusion

Prof. Liliang Li is an exceptional scientist whose work exemplifies innovation, rigor, and translational impact. Her integration of forensic science, molecular cardiology, and translational medicine has led to new insights into drug-induced cardiotoxicity and sudden cardiac death. With a remarkable combination of research excellence, leadership, and mentorship, Dr. Li continues to shape the future of cardiovascular and forensic research, making her a highly deserving candidate for the Excellence in Innovation Award.

Haiyan Li | Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Haiyan Li | Health Sciences | Best Researcher Award

Department of Breast Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University | China

Dr. Haiyan Li is a renowned Chief Physician at the Department of Breast Surgery, the Sixth Affiliated Hospital of Sun Yat-sen University. With a forward-thinking approach to breast oncology, she integrates surgical innovation and aesthetics, pioneering robotic-assisted reconstruction and minimally invasive techniques. As Chair of multiple breast surgery associations in Guangdong, she plays a pivotal role in training hundreds of surgeons across China, influencing clinical practice and elevating patient care standards. Her clinical contributions, academic publications, and leadership have established her as a national leader in aesthetic breast oncology.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Clinical and Academic Leadership: Dr. Li holds several prestigious leadership roles in surgical and medical societies related to breast oncology and reconstruction, indicating her influence in the field.

  2. Innovative Surgical Techniques: She has introduced novel approaches such as “Inverse Development Surgery” and “Defensive Surgical Strategy”, showing her commitment to innovation in patient-centered breast cancer care.

  3. Educational Contributions: As Chair of a key surgical committee, she has trained hundreds of surgeons across China, disseminating advanced minimally invasive techniques.

  4. Research Output:

    • 27 SCI/Scopus-indexed publications

    • A published book (ISBN: 978-7-5659-2929-8) with video demonstrations

    • 152 citations, reflecting moderate impact in her specialized field

    • Funded by the National Natural Science Foundation of China, a prestigious source

    • Robust focus on robotic-assisted surgery and aesthetic outcomes for breast cancer patients, a growing and highly relevant area

  5. Holistic Approach: Her focus on the aesthetic quality of life for breast cancer survivors integrates medical efficacy with psychological well-being, showing depth in translational research.

🎓 Education

Dr. Haiyan Li has built her medical and surgical career through rigorous academic and professional training. She completed her formal medical education and has continuously expanded her expertise in breast oncology and reconstructive surgery through national and international training programs. Her education laid a strong foundation for her specialization in robotic-assisted breast surgeries and innovative oncological approaches.

🩺 Experience

With extensive experience as a Chief Physician, Dr. Li has been instrumental in transforming breast cancer surgery in China. As the Chairperson of multiple professional committees under the Guangdong Medical Education Association and Guangdong Health Management Society, she has organized and led numerous national training workshops. Her signature innovations include the “Inverse Development Surgery” and “Defensive Surgical Strategy”, which are now recognized frameworks for aesthetic-preserving breast cancer operations.

🔬 Research Interests On Health Sciences

Dr. Li’s research is centered around minimally invasive surgery, robotic-assisted breast reconstruction, and aesthetic treatment in breast oncology. Recognizing the emotional and psychological impact of breast loss, her work emphasizes preserving the aesthetic and psychological well-being of patients. She has established a novel model of aesthetic oncology surgery, integrating functionality, oncologic safety, and beauty.

🏆 Awards

Dr. Haiyan Li has earned national recognition for her contributions to breast cancer aesthetics and surgical innovation. She is currently nominated for the Best Researcher Award for her groundbreaking advancements in robotic-assisted surgery and the aesthetic treatment of breast tumors. Her leadership in clinical training and innovation has significantly impacted breast oncology in China.

📚 Publications

Dr. Haiyan Li has authored over 27 peer-reviewed publications, focusing on breast cancer surgery, robotic techniques, and reconstruction. A selection of her key publications is below:

  1. Robotic-assisted nipple-sparing mastectomy with immediate breast reconstruction: initial experiences – Asian Journal of Surgery, 2019
    – Cited by: 35 articles

  2. Aesthetic considerations in oncological breast surgery: A Chinese perspective – The Breast, 2020
    – Cited by: 28 articles

  3. Minimally invasive axillary surgery in breast cancer treatment – Medicine (Baltimore), 2021
    – Cited by: 17 articles

  4. Defensive surgical strategies in breast oncology – Annals of Surgical Oncology, 2020
    – Cited by: 21 articles

  5. Integrating aesthetic outcomes in breast cancer care – Journal of the American College of Surgeons, 2018
    – Cited by: 29 articles

Total Citation Index: 152 📈
Her book 《Aesthetic Surgery of Breast Oncology》 (ISBN: 978-7-5659-2929-8) includes video tutorials and is widely used in medical training programs.

🔚 Conclusion

Dr. Haiyan Li has redefined breast cancer surgery by merging oncologic excellence with aesthetic preservation. Through her pioneering work in robotic-assisted surgeries, groundbreaking surgical strategies, and widespread training programs, she has significantly enhanced patient care and surgical education. Her work embodies innovation, empathy, and excellence, making her a deserving candidate for the Best Researcher Award.